Biogen's Empaveli cuts proteinuria 75% in teens with rare kidney disease
Tweet Send to a Friend
Biogen Inc. (Nasdaq: BIIB) announced the publication of results from a prespecified adolescent subgroup analysis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


